VTYX Ventyx Biosciences, Inc.
Healthcare$14.00+0.00%ClosedMarket Cap: $1.00B
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$14.00
Target (Median)
$14.00
Target Range
$14.00 - $14.00
Upside from current price: 0.0%
Rating Distribution
0 Strong Buy1 Buy7 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-01-08 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2026-01-08 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2026-01-08 | Oppenheimer | downgrade | Perform | Outperform |
| 2026-01-08 | Canaccord Genuity | downgrade | Hold | Buy |
| 2026-01-08 | UBS | downgrade | Neutral | Buy |
| 2026-01-08 | LifeSci Capital | downgrade | Market Perform | Outperform |
| 2025-11-07 | Wells Fargo | maintain | Overweight | Overweight |
| 2025-11-07 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-11-05 | HC Wainwright & Co. | upgrade | Buy | Neutral |
| 2025-10-27 | Oppenheimer | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-1.77 | $13.1M | 5 |
| Fri Dec 31 | $-1.60 | $30.6M | 6 |
| Sun Dec 31 | $-0.55 | $267.3M | 5 |
| Mon Dec 31 | $0.09 | $394.5M | 1 |